Tag: CD8+ T cells
Proteios Technology Awarded $1.6M NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology
eNewsChannels NEWS: -- Proteios Technology, Inc. is pleased to announce it's received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios' cell isolation kits to include up to 20 of the most common cell types currently used in cell therapy development.
